Esperion Therapeutics Income Statement - Quarterly (NASDAQ:ESPR)

Add to My Stocks
$48.8 $1.09 (2.28%) ESPR stock closing price Jul 24, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Esperion Therapeutics stock price. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. (See also:Esperion Therapeutics assets and Esperion Therapeutics free cash flow) View details of revenue and profits for Esperion Therapeutics for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4
Esperion Therapeutics Net Sales or Revenues
----------
Cost Of Goods Sold (COGS)----------
Esperion Therapeutics Gross Profit
----------
Research & Development Expense35.86M24.89M13.49M9.69M9.79M7.97M7.24M7.2M7.39M6.21M
Selling General & Admin Expense5.02M4.41M4.21M4.63M5.03M5.28M5.67M5.25M4.03M3.19M
Income Before Depreciation Depletion Amortization-40.88M-29.29M-17.71M-14.33M-14.82M-13.25M-12.91M-12.46M-11.42M-9.38M
Depreciation Depletion Amortization----------
Non Operating Income0.41M0.42M0.39M0.39M0.34M0.24M0.24M0.2M0.09M0.07M
Interest Expense0.06M0.09M0.08M0.09M0.11M0.13M0.13M0.13M0.13M0.14M
Esperion Therapeutics Pretax Income
-40.54M-28.96M-17.4M-14.03M-14.58M-13.13M-12.8M-12.39M-11.46M-9.47M
Provision for Income Taxes----------
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-40.54M-28.96M-17.4M-14.04M-14.59M-13.12M-12.8M-12.4M-11.47M-9.46M
Extraordinary Items & Discontinued Operations----------
Esperion Therapeutics Net Income (Profit/Loss)
-40.54M-28.96M-17.4M-14.04M-14.59M-13.12M-12.8M-12.4M-11.47M-9.46M
Average Shares used to compute Diluted EPS22.56M22.55M22.55M22.54M22.53M22.52M22.49M22.47M20.59M19.28M
Average Shares used to compute Basic EPS22.56M22.55M22.55M22.54M22.53M22.52M22.49M22.47M20.59M19.28M
Income Before Nonrecurring Items-40.54M-28.96M-17.4M-14.04M-14.59M-13.12M-12.8M-12.4M-11.47M-9.46M
Income from Nonrecurring Items----------
Esperion Therapeutics Earnings Per Share Basic Net
-1.80-1.29-0.77-0.62-0.65-0.58-0.57-0.55-0.56-0.49
Esperion Therapeutics Earnings Per Share Diluted Net
-1.80-1.29-0.77-0.62-0.65-0.58-0.57-0.55-0.56-0.49
EPS Diluted Before Nonrecurring Items-1.80-1.29-0.77-0.62-0.65-0.58-0.57-0.55-0.56-0.49
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Before investing one should read a report on Esperion Therapeutics stock analysis. Our Esperion Therapeutics revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate. An improving bottomline implies that the company is growing profits. The income statement is also called statement of revenue and expense. The financials along with Esperion Therapeutics historical stock prices provides a lot of details about the firm. .